SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-009338
Filing Date
2023-03-23
Accepted
2023-03-23 09:06:31
Documents
18
Period of Report
2023-03-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K celu-20230317.htm   iXBRL 8-K 84708
2 EX-10.1 celu-ex10_1.htm EX-10 342249
3 EX-10.2 celu-ex10_2.htm EX-10 205451
4 EX-10.3 celu-ex10_3.htm EX-10 331125
5 EX-10.4 celu-ex10_4.htm EX-10 247366
6 EX-10.5 celu-ex10_5.htm EX-10 128598
  Complete submission text file 0000950170-23-009338.txt   1658037

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT celu-20230317_def.xml EX-101.DEF 14174
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT celu-20230317_pre.xml EX-101.PRE 14184
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT celu-20230317.xsd EX-101.SCH 3461
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT celu-20230317_lab.xml EX-101.LAB 17766
12 EXTRACTED XBRL INSTANCE DOCUMENT celu-20230317_htm.xml XML 6500
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 23754652
SIC: 2834 Pharmaceutical Preparations